PolyPid PYPD
NASDAQ PYPD
$5.10 +0.02 (+0.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

PolyPid (PYPD) Non-Current Deffered Revenue (2022 - 2026)

PolyPid (PYPD) posted Non-Current Deffered Revenue of $2.5 million for Q1 2026, little changed sequentially from $2.5 million in Q4 2025, and little changed YoY from $2.5 million in Q1 2025.

PolyPid (PYPD) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends

PolyPid has reported Non-Current Deffered Revenue for 5 years, with the latest figure at $2.5 million in Q1 2026.

  • Quarterly Non-Current Deffered Revenue changed 0.0% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $2.5 million, changed 0.0% from the prior year.
  • Non-Current Deffered Revenue was little changed at $2.5 million in Q1 2026 per PYPD's latest filing, from $2.5 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $2.5 million in Q3 2022 and troughed at $2.5 million in Q3 2022.
  • A 5-year average of $2.5 million and a median of $2.5 million in 2022 frame the typical range for Non-Current Deffered Revenue.
  • The widest YoY moves for Non-Current Deffered Revenue: up 0.0% in 2023, down 0.0% in 2023.
  • Over 5 years, Non-Current Deffered Revenue stood at $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025, then changed by 0.0% to $2.5 million in 2026.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $2.5 million, $2.5 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 147.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 PolyPid 113.86 Mn 107.09 Mn - 2.55 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.55 Mn
Mar 31, 2026 2.55 Mn
Dec 31, 2025 2.55 Mn
Sep 30, 2025 2.55 Mn
Jun 30, 2025 2.55 Mn
Mar 31, 2025 2.55 Mn
Dec 31, 2024 2.55 Mn
Sep 30, 2024 2.55 Mn
Jun 30, 2024 2.55 Mn
Mar 31, 2024 2.55 Mn
Dec 31, 2023 2.55 Mn
Sep 30, 2023 2.55 Mn
Jun 30, 2023 2.55 Mn
Mar 31, 2023 2.55 Mn
Dec 31, 2022 2.55 Mn
Sep 30, 2022 2.55 Mn